BARCELONA, Spain — August 28, 2025 — Leads & Copy — Veeva Systems (NYSE: VEEV) has announced a collaboration with Amgen to advance clinical trial innovation. Amgen, a global biotechnology leader, will use the Veeva Clinical Platform to support efficiencies across the clinical trial process. This collaboration is part of Amgen’s commitment to accelerating the development of new medicines for patients with serious diseases.
Scott Skellenger, senior vice president and chief information officer at Amgen, stated that the collaboration with Veeva leverages advanced technology to unlock new capabilities for end-to-end trial operations, strengthening their ability to bring innovative treatments to patients quickly.
Jim Reilly, president of Veeva Development Cloud, expressed excitement in helping Amgen further advance clinical development. He said that the Veeva Clinical Platform will provide the backbone for standard and connected processes that can speed the delivery of life-saving drugs to patients.
As part of the collaboration, Veeva Business Consulting will support Amgen through implementation and change management.
Jeremy Whittaker, Veeva Systems, +49-695-095-5486, jeremy.whittaker@veeva.com
Source: Veeva Systems
